---
title: "Pulnovo Medical closes series C financing round in support of two US FDA trials"
date: "2025-03-03T12:03:16.000Z"
publishedDate: "3 mars 2025"
summary: "Pulnovo Medical has announced the closing of nearly US$100 million series C financing. The round was co-led by Qiming Venture Partners and existing shareholder Lilly Asia Ventures, with existing investors OrbiMed and Gaorong Capital participating on a super pro-rata basis."
importance: ""
sourceUrl: "https://cardiovascularnews.com/pulnovo-medical-series-c-financing-round/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-03-03-pulnovo-medical-closes-series-c-financing-round-in-support-of-two-us-fda-trials"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/08/red-blood-cells-flow-featured.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/pulnovo-medical-series-c-financing-round/"
---

![Pulnovo Medical closes series C financing round in support of two US FDA trials](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/08/red-blood-cells-flow-featured.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/pulnovo-medical-series-c-financing-round/*

## L’essentiel

Pulnovo Medical has announced the closing of nearly US$100 million series C financing. The round was co-led by Qiming Venture Partners and existing shareholder Lilly Asia Ventures, with existing investors OrbiMed and Gaorong Capital participating on a super pro-rata basis.

## Lien source

https://cardiovascularnews.com/pulnovo-medical-series-c-financing-round/
